TAS0612

· Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS0612, covering 2025-03-13 to 2025-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer [Phase 1]